Oct 26, 2026 08:45AM
Oct 26, 2026 08:45AM
Oct 16, 2026 08:00AM
Oct 16, 2026 08:00AM
Oct 1, 2026 08:01AM
Oct 1, 2026 08:00AM
Sep 8, 2026 08:00AM Azitra, Inc. to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Aug 21, 2026 08:00AM
Aug 21, 2026 08:00AM
Aug 12, 2026 05:00PM
Jul 15, 2026 10:11AM
Jul 15, 2026 10:10AM
Jun 17, 2026 08:03AM
Jun 17, 2026 08:00AM Azitra, Inc. CEO Issues Letter to Shareholders Detailing Strategic Reorientation Initiatives and Outlook for 2026 and Beyond
Jun 16, 2026 05:28PM
Jun 4, 2026 04:05PM
May 27, 2026 04:30PM
May 13, 2026 08:30AM
May 6, 2026 08:02AM
May 6, 2026 08:00AM
Apr 28, 2026 08:02AM Azitra, Inc. Announces Poster Presentation at ASGCT 2026 Highlighting ATR-01 Program for Ichthyosis Vulgaris
Mar 19, 2026 01:14PM
Mar 19, 2026 01:13PM
Mar 13, 2026 05:16PM
Mar 13, 2026 05:15PM
Mar 5, 2026 04:30PM
Feb 27, 2026 05:30PM
Feb 24, 2026 08:00AM Azitra, Inc. Announces Addition of MD Anderson Cancer Center as Clinical Site for Phase 1/2 Trial of ATR-04 Targeting EGFRi-Associated Skin Rash
Feb 19, 2026 08:00AM
Feb 6, 2026 04:15PM
Dec 17, 2025 04:10PM
Dec 17, 2025 04:10PM
Nov 12, 2025 05:15PM
Nov 7, 2025 06:00AM
Nov 7, 2025 06:00AM Azitra, Inc. Addresses False Report Regarding Sale of Securities
Oct 20, 2025 08:02AM
Oct 20, 2025 08:02AM
Oct 15, 2025 04:05PM
Oct 3, 2025 04:45PM
Oct 3, 2025 04:45PM
Sep 4, 2025 08:10AM
Aug 27, 2025 08:10AM Azitra doses first patient in trial for cancer rash treatment
Aug 27, 2025 08:10AM
Aug 11, 2025 04:15PM
Aug 11, 2025 04:15PM
Jun 17, 2025 08:02AM
Jun 17, 2025 08:02AM
Jun 10, 2025 08:33AM
May 28, 2025 08:33AM Azitra, Inc. Announces Presentation at ASCO 2025 Highlighting Clinical Trial Investigating ATR-04 for EGFRi-Associated Rash
May 14, 2025 04:05PM

335,386 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All